(S)-2-(((Benzyloxy)carbonyl)amino)pent-4-enoic acid

Catalog No.: 
ACUASF275
CAS No.: 
78553-51-2
Molecular Formula: 
C13H15NO4
Molecular Weight: 
249.27
(S)-2-(((Benzyloxy)carbonyl)amino)pent-4-enoic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g98%
25g98%

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(S)-2-(((Benzyloxy)carbonyl)amino)pent-4-enoic acid
IUPAC Name(S)-2-(((benzyloxy)carbonyl)amino)pent-4-enoic acid
MDL No.MFCD02094548
Molecular FormulaC13H15NO4
Molecular Weight249.27
SMILESC=CC[C@H](NC(OCC1=CC=CC=C1)=O)C(O)=O
InChI KeyDGEZDWGCGXHLEW-NSHDSACASA-N
Synonym78553-51-2 | (S)-2-(((Benzyloxy)carbonyl)amino)pent-4-enoic acid | (S)-2-(benzyloxycarbonylamino)pent-4-enoic acid | (2S)-2-(phenylmethoxycarbonylamino)pent-4-enoic acid | (2S)-2-{[(benzyloxy)carbonyl]amino}pent-4-enoic acid | (S)-N-CBZ-2-(AMINO)PENT-4-ENOIC ACID | (
CAS No.78553-51-2
PubChem CID11776816

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACUASF275 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACZWKP205 route compound structure diagram
    ACZWKP20516338-48-0In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACUASF275 route product structure diagram
    ACUASF27578553-51-2In Stock
Inquiry

2. ACUASF275 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACUASF275 route product structure diagram
    ACUASF27578553-51-2In Stock
Inquiry

3. ACUASF275 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACUASF275 route product structure diagram
    ACUASF27578553-51-2In Stock
Inquiry

Comments (0)